• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 扰乱肾素-血管紧张素系统和能量代谢。

SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.

机构信息

Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.

Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E43-E47. doi: 10.1152/ajpendo.00219.2020. Epub 2020 May 29.

DOI:10.1152/ajpendo.00219.2020
PMID:32469255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7322507/
Abstract

The COVID-19 pandemic, caused by the novel coronavirus, SARS-CoV-2, is threating our health systems and daily lives and is responsible for causing substantial morbidity and mortality. In particular, aged individuals and individuals with comorbidities, including obesity, diabetes mellitus, and hypertension, have significantly higher risks of hospitalization and death than normal individuals. The renin-angiotensin system (RAS) plays a pivotal role in the pathogenesis of diabetes mellitus, obesity, and hypertension. Angiotensin-converting enzyme 2 (ACE2), belonging to the RAS family, has received much attention during this COVID-19 pandemic, owing to the fact that SARS-CoV-2 uses ACE2 as a receptor for cellular entry. Additionally, the RAS greatly affects energy metabolism in certain pathological conditions, including cardiac failure, diabetes mellitus, and viral infections. This article discusses the potential mechanisms by which SARS-CoV-2 modulates the RAS and energy metabolism in individuals with obesity and diabetes mellitus. The article aims to highlight the appropriate strategies for combating the COVID-19 pandemic in the clinical setting and emphasize on the areas that require further investigation in relation to COVID-19 infections in patients with obesity and diabetes mellitus from the viewpoint of endocrinology and metabolism.

摘要

新型冠状病毒引起的 COVID-19 大流行正在威胁我们的医疗体系和日常生活,并导致大量发病和死亡。特别是老年人和合并症患者(包括肥胖、糖尿病和高血压)的住院和死亡风险明显高于一般人群。肾素-血管紧张素系统(RAS)在糖尿病、肥胖和高血压的发病机制中起关键作用。血管紧张素转换酶 2(ACE2)属于 RAS 家族,在 COVID-19 大流行期间受到了广泛关注,因为 SARS-CoV-2 利用 ACE2 作为细胞进入的受体。此外,RAS 在某些病理情况下(包括心力衰竭、糖尿病和病毒感染)对能量代谢有很大影响。本文讨论了 SARS-CoV-2 在肥胖和糖尿病患者中调节 RAS 和能量代谢的潜在机制。本文旨在强调在临床环境中对抗 COVID-19 大流行的适当策略,并从内分泌和代谢的角度强调肥胖和糖尿病患者 COVID-19 感染相关需要进一步研究的领域。

相似文献

1
SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.SARS-CoV-2 扰乱肾素-血管紧张素系统和能量代谢。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E43-E47. doi: 10.1152/ajpendo.00219.2020. Epub 2020 May 29.
2
SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.SARS-CoV-2 感染与 ACE2:与糖尿病患者发病率和死亡率增加相关的临床结局。
Diabetes. 2020 Sep;69(9):1875-1886. doi: 10.2337/dbi20-0019. Epub 2020 Jul 15.
3
Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.肾素-血管紧张素系统抑制剂在 COVID-19 大流行期间高血压管理中的应用。
J Physiol Pharmacol. 2020 Apr;71(2). doi: 10.26402/jpp.2020.2.01. Epub 2020 Jul 2.
4
Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.肾素-血管紧张素系统的遗传学假说和药物遗传学在 COVID-19 中的作用。
Genes (Basel). 2020 Sep 3;11(9):1044. doi: 10.3390/genes11091044.
5
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.严重急性呼吸综合征冠状病毒2型发病机制:肾素-血管紧张素系统失衡促进肺纤维化。
Front Cell Infect Microbiol. 2020 Jun 12;10:340. doi: 10.3389/fcimb.2020.00340. eCollection 2020.
6
Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.肾素-血管紧张素系统:急性呼吸窘迫综合征发病机制中的重要角色。
Int J Mol Sci. 2020 Oct 28;21(21):8038. doi: 10.3390/ijms21218038.
7
Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的中枢神经系统受累可能会加重急性呼吸窘迫综合征(ARDS)和高血压。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972015. doi: 10.1177/1470320320972015.
8
[ACE2 and coronavirus - a question of balance and dynamics?].[血管紧张素转换酶2与冠状病毒——平衡与动态变化的问题?]
Lakartidningen. 2020 Apr 17;117:F3S3.
9
Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?了解 COVID-19 的病理生理学:接触系统是否可能是关键?
Front Immunol. 2020 Aug 11;11:2014. doi: 10.3389/fimmu.2020.02014. eCollection 2020.
10
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].[肾素-血管紧张素系统(RAS)与2019冠状病毒病——关于RAS阻滞剂的处方]
Pneumologie. 2020 Sep;74(9):611-614. doi: 10.1055/a-1165-6994. Epub 2020 Sep 11.

引用本文的文献

1
Severe COVID-19 infection: An institutional review and literature overview.严重 COVID-19 感染:机构审查和文献综述。
PLoS One. 2024 Aug 20;19(8):e0304960. doi: 10.1371/journal.pone.0304960. eCollection 2024.
2
SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy.SARS-CoV-2 刺突蛋白通过减少线粒体自噬诱导 IL-18 介导的心肺炎症。
Signal Transduct Target Ther. 2023 Mar 9;8(1):108. doi: 10.1038/s41392-023-01368-w.
3
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches.长期新冠:临床框架、生物标志物及治疗方法
J Pers Med. 2023 Feb 15;13(2):334. doi: 10.3390/jpm13020334.
4
Mechanisms of COVID-19 pathogenesis in diabetes.COVID-19 发病机制在糖尿病中的研究进展。
Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H403-H420. doi: 10.1152/ajpheart.00204.2022. Epub 2022 Jul 1.
5
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19.细胞死亡:在 COVID-19 发病机制和干预治疗中的作用。
Signal Transduct Target Ther. 2022 Jun 13;7(1):186. doi: 10.1038/s41392-022-01043-6.
6
A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection.新型冠状病毒肺炎(COVID-19)感染相关血栓形成风险的病理生理机制、诊断及治疗综述
Int J Cardiol Heart Vasc. 2022 Aug;41:101068. doi: 10.1016/j.ijcha.2022.101068. Epub 2022 Jun 3.
7
COVID-19 and One-Carbon Metabolism.COVID-19 与一碳代谢。
Int J Mol Sci. 2022 Apr 10;23(8):4181. doi: 10.3390/ijms23084181.
8
Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study.从肾素-血管紧张素-醛固酮系统的角度评估钠-葡萄糖共转运蛋白-2 抑制剂在 COVID-19 感染患者中的作用:从达格列净治疗 COVID-19 呼吸衰竭患者研究中的发现进行背景分析。
Mol Biol Rep. 2022 Mar;49(3):2321-2324. doi: 10.1007/s11033-022-07183-w. Epub 2022 Jan 31.
9
Pandemics of the 21st Century: The Risk Factor for Obese People.21 世纪的大流行疾病:肥胖人群的致病因素。
Viruses. 2021 Dec 23;14(1):25. doi: 10.3390/v14010025.
10
Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets.冠状病毒感染相关细胞死亡信号转导及潜在治疗靶点
Molecules. 2021 Dec 9;26(24):7459. doi: 10.3390/molecules26247459.

本文引用的文献

1
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.TMPRSS2 和 TMPRSS4 促进 SARS-CoV-2 感染人小肠肠细胞。
Sci Immunol. 2020 May 13;5(47). doi: 10.1126/sciimmunol.abc3582.
2
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.血管紧张素转换酶 2:SARS-CoV-2 受体和肾素-血管紧张素系统的调节剂:庆祝 ACE2 发现 20 周年。
Circ Res. 2020 May 8;126(10):1456-1474. doi: 10.1161/CIRCRESAHA.120.317015. Epub 2020 Apr 8.
3
Diabetes is a risk factor for the progression and prognosis of COVID-19.糖尿病是新冠病毒疾病(COVID-19)进展和预后的一个风险因素。
Diabetes Metab Res Rev. 2020 Oct;36(7):e3319. doi: 10.1002/dmrr.3319. Epub 2020 Apr 7.
4
COVID-19 pandemic, coronaviruses, and diabetes mellitus.COVID-19 大流行、冠状病毒和糖尿病。
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741. doi: 10.1152/ajpendo.00124.2020. Epub 2020 Mar 31.
5
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
6
Angiotensin Converting Enzyme 2: A Double-Edged Sword.血管紧张素转换酶2:一把双刃剑。
Circulation. 2020 Aug 4;142(5):426-428. doi: 10.1161/CIRCULATIONAHA.120.047049. Epub 2020 Mar 26.
7
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.肾素-血管紧张素系统阻滞剂与 COVID-19 大流行:目前尚无证据表明应放弃使用肾素-血管紧张素系统阻滞剂。
Hypertension. 2020 Jun;75(6):1382-1385. doi: 10.1161/HYPERTENSIONAHA.120.15082. Epub 2020 Mar 25.
8
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
9
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.单细胞 RNA 测序数据分析受体 ACE2 的表达揭示了不同人体器官易感染 2019-nCoV 的潜在风险。
Front Med. 2020 Apr;14(2):185-192. doi: 10.1007/s11684-020-0754-0. Epub 2020 Mar 12.
10
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.严重急性呼吸系统综合征冠状病毒 2 刺突糖蛋白的结构、功能和抗原性。
Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9.